^
Association details:
Evidence:
Evidence Level:
Sensitive: C4 – Case Studies
Source:
Title:

Response to RET-Specific Therapy in RET Fusion-Positive Anaplastic Thyroid Carcinoma

Published date:
04/16/2020
Excerpt:
This clinically significant response achieved with LOXO-292 in a patient with a CCDC6-RET fusion-positive ATC…
DOI:
10.1089/thy.2019.0477